Cargando…
地西他滨治疗难治性贫血伴有原始细胞过多的疗效和不良反应与治疗疗程数的关系
OBJECTIVE: To explore the impact of decitabine treatment cycles on efficacy and adverse events (AEs) in patients of myelodysplastic syndrome-refractory anemia with excess blasts (MDSRAEB). METHODS: A total of fifty-six patients with MDS-RAEB who received decitabine 20 mg·m(−2)·d(−1)by IV infusion da...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364885/ https://www.ncbi.nlm.nih.gov/pubmed/27801319 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.10.011 |